Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

The vitamin D receptor can act without its usual activating molecule, affecting hair growth and skin cancer, but its full range of actions is not well understood.

Human dermal stem/progenitor cells can divide and differentiate more than hair follicle dermal papilla cells.

A woman's unique dementia was misdiagnosed, a genetic mutation increases Parkinson's risk with age, and finasteride may help with Tourette syndrome.

HPDAlR nanoparticles greatly improve skin wound healing without toxicity.

DPSCs and SHED have great potential for medical treatments and tissue repair.

Prolactin affects hair growth cycles and can cause early hair follicle regression.

A cholesterol-free liposomal platform using protopanaxadiol effectively promotes hair growth and treats alopecia.

Activated platelet-rich plasma helps hair growth by boosting growth factors and cell growth pathways in hair cells.

The vitamin D receptor is crucial for bone health and affects various body systems, with mutations potentially leading to disease.

Inhibiting PLA2 enzymes may help treat inflammatory skin diseases like psoriasis and dermatitis.

Vitamin D receptor helps control hair growth genes in skin cells.

UTMD with diclofenac and Doxil® improves cancer treatment by boosting immune response and reducing tumor-supporting cells.

TDM10842, a thyroid hormone receptor activator, was found to effectively promote hair growth in mice.

mrp/plf-mRNA can indicate tumor-promoting effects in skin.

Adjusting estradiol-ANGPT2 levels can promote hair growth in female pattern hair loss.

DS-2325a is safe and well-tolerated, supporting further development for Netherton Syndrome treatment.

Dihydrotestosterone increases the activity of an enzyme in pubic skin cells that converts testosterone to dihydrotestosterone.

Dupilumab significantly improved a 5-year-old girl's prurigo nodularis without side effects.

A specific gene mutation causes vitamin D resistance, but certain vitamin D analogs might help.

New treatments for cancer and skin disorders show promise in disrupting harmful cell interactions and promoting hair growth.

Three characteristics of plasmacytoid dendritic cells help tell apart lupus-related hair loss from LPP.

Phosphodiesterase inhibitors like tadalafil can reduce cell growth in BPH caused by CD8+ T cells in low androgen conditions.

A protein called PCBP2 controls the production of a hair growth protein by interacting with its genetic message and is linked to hair loss when this control is disrupted.

Type 3 5α-reductase is more common and finasteride and dutasteride strongly inhibit it.

Diphenylcyclopropenone (DPCP) is effective in treating alopecia areata, with most patients showing significant hair regrowth.

Mutations at Val-889 and Arg-752 disrupt key interactions in the androgen receptor, affecting its function.

Blocking DPP4 can help activate hair growth and improve hair regeneration.

α-Phellandrene may help prevent hair loss by increasing growth factors and cell growth in hair cells through a specific signaling pathway.

LMWP-PDGFA shows promise for improving hair health and treating hair loss with fewer side effects.